Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2020
Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency InitiativeLucinda S Orsini, Marc Berger, William Crown, et al.Frontiers in Public Health|May 14, 2023
Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessmentAntal Zemplényi, Konstantin Tachkov, Laszlo Balkanyi, et al.Journal of Market Access & Health Policy|July 29, 2024
The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access AcademyElaine Julian, Oriol Solà-Morales, Maria João Garcia, et al.Journal of Market Access & Health Policy|March 28, 2024
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and CollaboratorsThomas Desmet, Elaine Julian, Walter Van Dyck, et al.International Journal of Technology Assessment in Health Care|June 16, 2023
Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working GroupMilou Amber Hogervorst, Rick Vreman, Inkatuuli Heikkinen, et al.Pharmacoepidemiology and Drug Safety|October 10, 2022
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task forceShirley V Wang, Anton Pottegård, William Crown, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 14, 2022
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task ForceShirley V Wang, Anton Pottegård, William Crown, et al.Journal of Market Access & Health Policy|June 7, 2023
The role of stakeholder involvement in the evolving EU HTA process: Lauren Van Haesendonck, Jörg Ruof, Thomas Desmet, et al.Health Science Reports|January 29, 2026
Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European CountriesZoltán Kaló, Guenka Petrova, Bertalan Németh, et al.Frontiers in Public Health|July 19, 2023
Recommendations for patient involvement in health technology assessment in Central and Eastern European countriesIvett Jakab, Maria Dimitrova, François Houÿez, et al.Pageof 6